Josep Ramon Germà Lluch-rekin lankidetzan egindako argitalpenak (9)

2011

  1. Brief report: Phase II multicenter study of temozolomide in patients with cisplatin-resistant germ cell tumors

    Oncology, Vol. 80, Núm. 3-4, pp. 219-222

2010

  1. Treatment of cancer with oral drugs: A position statement by the Spanish Society of Medical Oncology (SEOM)

    Annals of Oncology

2008

  1. European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II

    European Urology, Vol. 53, Núm. 3, pp. 497-513

  2. European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I

    European Urology, Vol. 53, Núm. 3, pp. 478-496

2005

  1. Multicentre risk-adapted management for stage I non-seminomatous germ cell tumours

    Annals of Oncology, Vol. 16, Núm. 12, pp. 1915-1920

  2. Risk-adapted management for patients with clinical stage I seminoma: The second Spanish Germ Cell Cancer Cooperative Group study

    Journal of Clinical Oncology, Vol. 23, Núm. 34, pp. 8717-8723

2003

  1. Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma

    Annals of Oncology, Vol. 14, Núm. 6, pp. 867-872

2002

  1. Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: The experience of the Spanish Germ-Cell Cancer Group (GG)

    European Urology, Vol. 42, Núm. 6, pp. 553-563

  2. Phase II multicentre study of docetaxel plus cisplatin in patients with advanced urothelial cancer

    British Journal of Cancer, Vol. 86, Núm. 3, pp. 326-330